drugset / Trial / NCT00389831
Efficacy, Safety and Tolerability of Rotigotine Nasal Spray for the Acute Treatment of RLS Symptoms
RandomizedParallel-groupDouble-blindTreatment
Summary
The main objective of this phase 2a proof-of-concept trial is to assess the efficacy of rotigotine nasal spray in ascending doses in subjects with idiopathic Restless Legs Syndrome.
Timeline
- Start
- 2006-08
- Primary completion
- 2006-11
- Completion
- 2006-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rotigotine | Unknown | 62 ug | Intranasal |
| Subject | Rotigotine | Unknown | 124 ug | Intranasal |
| Subject | Rotigotine | Unknown | 247 ug | Intranasal |